Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cytotools announces positive results in interim evaluation of European ulcer cruris study

June 29 (Reuters) - Cytotools AG  T5OG.DE : 
    * Announces positive results in the interim evaluation of 
European ulcer cruris study 
    * Continuation of the study as a phase III pivotal study 
with 260 patients 
 
Source text for Eikon:  ID:nEQ3ltL2ra  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on bioXXmed AG

See all news